An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

National Agricultural Library
U.S. Department of Agriculture
  1. Home
  2. Human Nutrition and Food Safety
  3. Research Publications (Food Safety)

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 26 - 50 of 178

  1. Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study

    • International Journal of Antimicrobial Agents

    • Author(s): Firouzé Bani-Sadr, Maxime Hentzien, Madeline Pascard, Yohan N'Guyen, Amélie Servettaz, Laurent Andreoletti, Lukshe Kanagaratnam, Damien Jolly

      • COVID-19

  2. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic

    • International Journal of Antimicrobial Agents

    • Author(s): Satyajit Tripathy, Barsha Dassarma, Somenath Roy, Hlupheka Chabalala, Motlalepula Gilbert Matsabisa

      • COVID-19

  3. Extra-respiratory manifestations of COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Chih-Cheng Lai, Wen-Chien Ko, Ping-Ing Lee, Shio-Shin Jean, Po-Ren Hsueh

      • COVID-19

  4. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

    • International Journal of Antimicrobial Agents

    • Author(s): Jacques Fantini, Henri Chahinian, Nouara Yahi

      • COVID-19

  5. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

    • International Journal of Antimicrobial Agents

    • Author(s): Ran Yu, Liang Chen, Rong Lan, Rong Shen, Peng Li

      • COVID-19

  6. Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Hua Shi, Chaomin Zhou, Pinghong He, Sheng Huang, Youjun Duan, Xuesheng Wang, Kexiong Lin, Chao Zhou, Xiangyan Zhang, Yan Zha

      • COVID-19

  7. Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors

    • International Journal of Antimicrobial Agents

    • Author(s): Jun He, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, Wencai Ye

      • COVID-19

  8. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

    • International Journal of Antimicrobial Agents

    • Author(s): Atul Sharma, Swapnil Tiwari, Manas Kanti Deb, Jean Louis Marty

      • COVID-19

  9. Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): J. Homolak, I. Kodvanj

      • COVID-19

  10. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

    • International Journal of Antimicrobial Agents

    • Author(s): Naveen Vankadari

      • COVID-19

  11. Procalcitonin levels in COVID-19 patients

    • International Journal of Antimicrobial Agents

    • Author(s): Rui Hu, Chaofei Han, Shiyao Pei, Mingzhu Yin, Xiang Chen

      • COVID-19

  12. Is teicoplanin a complementary treatment option for COVID-19? The question remains

    • International Journal of Antimicrobial Agents

    • Author(s): Giancarlo Ceccarelli, Francesco Alessandri, Gabriella d'Ettorre, Cristian Borrazzo, Ornella Spagnolello, Alessandra Oliva, Franco Ruberto, Claudio M. Mastroianni, Francesco Pugliese, Mario Venditti, Intensive Care COVID-19 Study Group of Sapienza University

      • COVID-19

  13. Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports

    • International Journal of Antimicrobial Agents

    • Author(s): Valeria Gaspari, Corrado Zengarini, Sonia Greco, Valeria Vangeli, Antonio Mastroianni

      • COVID-19

  14. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

    • International Journal of Antimicrobial Agents

    • Author(s): Arturo Ciccullo, Alberto Borghetti, Lorenzo Zileri Dal Verme, Alberto Tosoni, Francesca Lombardi, Matteo Garcovich, Federico Biscetti, Massimo Montalto, Roberto Cauda, Simona Di Giambenedetto, GEMELLI AGAINST COVID Group

      • COVID-19

  15. Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

    • International Journal of Antimicrobial Agents

    • Author(s): Sun In Hong, Byung-Han Ryu, Yong Pil Chong, Seungjun Lee, Sunjoo Kim, Ho Cheol Kim, Kyung-Wook Hong, In-Gyu Bae, Oh-Hyun Cho

      • COVID-19

  16. Tocilizumab administration in a refractory case of COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Payam Tabarsi

      • COVID-19

  17. Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time

    • International Journal of Antimicrobial Agents

    • Author(s): Benjamin Davido, Ghilas Boussaid, Isabelle Vaugier, Thibaud Lansaman, Frédérique Bouchand, Christine Lawrence, Jean-Claude Alvarez, Pierre Moine, Véronique Perronne, Frédéric Barbot, Azzam Saleh-Mghir, Christian Perronne, Djillali Annane, Pierre De Truchis, COVID-19 RPC Team

      • COVID-19

  18. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results

    • International Journal of Antimicrobial Agents

    • Author(s): Alexandre Lopez, Gary Duclos, Bruno Pastene, Karine Bezulier, Romain Guilhaumou, Caroline Solas, Laurent Zieleskiewicz, Marc Leone

      • COVID-19

  19. Erratum to ``A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence'' [International Journal of Antimicrobial Agents 55/6 (2020) 105948]

    • International Journal of Antimicrobial Agents

    • Author(s): Lisheng Wang, Yiru Wang, Dawei Ye, Qingquan Liu

      • COVID-19

  20. Publishing in face of the COVID-19 pandemic

    • International Journal of Antimicrobial Agents

    • Author(s): Andreas Voss, Geoffrey Coombs, Serhat Unal, Raphael Saginur, Po-Ren Hsueh

      • COVID-19

  21. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

    • International Journal of Antimicrobial Agents

    • Author(s): Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira, Hervé Tissot Dupont, Stéphane Honoré, Philippe Colson, Eric Chabrière, Bernard La Scola, Jean-Marc Rolain, Philippe Brouqui, Didier Raoult

      • COVID-19

  22. Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949

    • International Journal of Antimicrobial Agents

    • Author(s): Frits R. Rosendaal

      • COVID-19

  23. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

    • International Journal of Antimicrobial Agents

    • Author(s): Julian D Machiels, Chantal P Bleeker-Rovers, Rob ter Heine, Janette Rahamat-Langendoen, Quirijn de Mast, Jaap ten Oever, Teun Bousema, Reinout van Crevel, Heiman FL Wertheim

      • COVID-19

  24. Tocilizumab for severe COVID-19: a systematic review and meta-analysis

    • International Journal of Antimicrobial Agents

    • Author(s): Shao-Huan Lan, Chih-Cheng Lai, Hui-Ting Huang, Shen-Peng Chang, Li-Chin Lu, Po-Ren Hsueh

      • COVID-19

  25. Ribavirin therapy for severe COVID-19: a retrospective cohort study

    • International Journal of Antimicrobial Agents

    • Author(s): Song Tong, Yuan Su, Yuan Yu, Chuangyan Wu, Jiuling Chen, Sihua Wang, Jinjun Jiang

      • COVID-19